Extubation Criteria in Patients Greater Than 59 Years of Age
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Oct 14, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how certain criteria can help predict whether patients aged 60 and older will successfully breathe on their own after surgery. The researchers want to see if specific signs and tests can guide doctors in deciding when it's safe to take patients off the breathing machine (extubation) after they have undergone general anesthesia for surgery or other medical procedures.
To participate in this study, patients must be at least 60 years old and scheduled for a procedure where they are expected to be taken off the breathing machine right after. However, those who have certain conditions, such as needing a breathing tube placed before the procedure or having a heart surgery, won’t be eligible. If you join the trial, you’ll be monitored closely to see how well you recover from anesthesia and whether the criteria predicted your success in breathing independently. This research aims to improve safety and outcomes for older adults undergoing surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>= 60 years of age
- • Patients undergoing general endotracheal anesthesia for surgery or invasive diagnostic procedures that are anticipated to be extubated immediately following the procedure
- Exclusion Criteria:
- • Age\<60 years of age
- • Patients with a tracheostomy in - situ (pre-existing or placed as part of the index procedure)
- • Patients undergoing cardiac surgical procedures
- • Patients undergoing general endotracheal anesthesia who are not anticipated to be extubated immediately following the surgical procedure
- • Patients with delayed extubations in the post anesthesia care unit or intensive care unit)
- • Patients undergoing TIVA (Total Intravenous Anaesthesia)
- • Patient with an initial room air SpO2\<93%
- • Patients with VADS (ventricular assist device) undergoing non-cardiac surgery
- • Thoracic surgical procedures
- • Patients on home oxygen
- • Patients getting general anesthesia with supraglottic airway
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Thomas W Templeton, MD
Principal Investigator
Wake Forest Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials